The majority of lupus patients (12 out of 14) had active SLE (SLEDAI > 4) at baseline (S1) as evidenced by their low mean ± standard deviation (SD) serum C3 and C4, and high anti-dsDNA levels (Table 1). Here, C4A is linked to systemic lupus erythematosus.